HASHEM EL-SERAG to Cost-Benefit Analysis
This is a "connection" page, showing publications HASHEM EL-SERAG has written about Cost-Benefit Analysis.
Connection Strength
0.406
-
Reply: To PMID 24957400. Dig Dis Sci. 2015 Feb; 60(2):587.
Score: 0.098
-
Cost-effectiveness and diagnostic effectiveness analyses of multiple algorithms for the diagnosis of Lynch syndrome. Dig Dis Sci. 2014 Dec; 59(12):2913-26.
Score: 0.094
-
Surveillance in Barrett's esophagus: lessons from behavioral economics. Gastroenterology. 2009 Sep; 137(3):763-5.
Score: 0.067
-
Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysis. Arch Intern Med. 2002 Oct 14; 162(18):2105-10.
Score: 0.042
-
Surveillance for hepatocellular carcinoma: does it work? Am J Gastroenterol. 2002 Oct; 97(10):2676-7.
Score: 0.042
-
Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis. Ann Intern Med. 2000 Feb 15; 132(4):261-9.
Score: 0.035
-
Economic aspects of endoscopic screening for intestinal precancerous conditions. Gastrointest Endosc Clin N Am. 1997 Jan; 7(1):165-84.
Score: 0.028